Ulrike Marczak

Ulrike Marczak serves as the CEO of Vanguard AG - Medical Remanufacturing since January 2022 and previously held the position of Geschäftsführerin at Angiokard Medizintechnik GmbH from May 2013 to December 2021. Prior to this, Ulrike Marczak worked at Vanguard AG in various roles from April 2009 to April 2013, including Leiterin Operations, Geschäftsbereichsleitung Systemlösungen für Medizinprodukte, and Standortleitung Werk Berlin, focusing on the reprocessing of single-use and reusable instruments. Ulrike Marczak's career began at Biomet, where responsibilities included production management and leading various operational teams from October 2000 to March 2009. Ulrike Marczak holds a Diplom-Wirtschaftsingenieur degree from Hochschule Stralsund, specializing in engineering sciences.